Q2 2024 Holdings
Filed 2024-08-14 | 6 holdings | $182.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc.(TRDA) | Common | 29384C108 | $63.1M | 4,425,784 | 34.6% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $55.1M | 1,561,496 | 30.3% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $40.6M | 2,738,785 | 22.3% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $10.5M | 4,284,172 | 5.7% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $7.4M | 2,242,636 | 4.1% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $5.4M | 5,555,461 | 3.0% |